A Phase 2 Study of Temsirolimus (CCI-779) in Patients With Soft Tissue Sarcomas: A Study of the Mayo Phase 2 Consortium (P2C)

BACKGROUND: The primary goal of this trial was to evaluate the confirmed response rate of temsirolimus (CCI-779), a mammalian target of rapamycin in patients with advanced soft tissue sarcomas (STS). METHODS: Patients ≥18 years with measurable advanced STS, no prior chemotherapy for metastatic disea...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Okuno, Scott, Bailey, Howard, Mahoney, Michelle R., Adkins, Douglas, Maples, William, Fitch, Tom, Ettinger, David, Erlichman, Charles, Sarkaria, Jann N.
Format: Artigo
Sprog:Inglês
Udgivet: 2011
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3312920/
https://ncbi.nlm.nih.gov/pubmed/21287536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25928
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker